Ryk, C., Koskela, L. R., Thiel, T., Wiklund, N. P., Steineck, G., Schumacher, M. C., & de Verdier, P. J. (2015). Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes(). Redox Biol.
シカゴスタイル引用形Ryk, Charlotta, Lotta Renström Koskela, Tomas Thiel, N. Peter Wiklund, Gunnar Steineck, Martin C. Schumacher, , Petra J. de Verdier. "Outcome After BCG Treatment for Urinary Bladder Cancer May Be Influenced By Polymorphisms in the NOS2 and NOS3 Genes()." Redox Biol 2015.
MLA引用形式Ryk, Charlotta, et al. "Outcome After BCG Treatment for Urinary Bladder Cancer May Be Influenced By Polymorphisms in the NOS2 and NOS3 Genes()." Redox Biol 2015.
警告: この引用は必ずしも正確ではありません.